Ahmed ClearPath glaucoma drainage device launches

August 22, 2019
The Ahmed ClearPath glaucoma drainage device has been commercially launched in the United States, New World Medical announced in a press release…

In the Journals

Once-daily netarsudil noninferior to twice-daily timolol in phase 3 study

August 21, 2019
Once-daily netarsudil was noninferior to twice-daily timolol for IOP-lowering efficacy in patients with open-angle glaucoma or ocular hypertension…

Graybug Vision completes Series C financing

August 21, 2019
Graybug Vision has closed $80 million in Series C financing, which will be used to advance its pan-VEGF inhibitor GB-102 into phase 2 studies and its…

Five FDA ophthalmology updates you might have missed

August 17, 2019
The FDA has issued multiple approvals and denials of drugs, formulations and devices over the past month. Here are five recent ophthalmology-related…

Patients with glaucoma at higher risk for motor vehicle accidents

August 15, 2019
Older drivers with glaucoma are involved in automobile accidents at a higher rate than their similarly aged counterparts without glaucoma, according…

Quality of sleep associated with glaucoma

August 14, 2019
Poor sleep parameters, including sleep duration, latency and daytime dysfunction, are associated with glaucoma, either as a risk factor or as a…

Alembic’s generic dorzolamide hydrochloride solution approved

August 13, 2019
Alembic Pharmaceuticals’ abbreviated new drug application for dorzolamide hydrochloride ophthalmic solution USP 2% has been approved by the…

Blog

BLOG: Applying risk management to clinical practice

August 12, 2019
Risk assessment and risk management are common tools in modern society. Although the concept can be traced back to the ancient Greeks from around 400…

Bimatoprost SR NDA acceptance tops July glaucoma news

August 8, 2019
July’s glaucoma news included updates on trial enrollments and study results. Here are the top five glaucoma-related articles on…

In the Journals

Phaco plus goniosynechialysis adds no IOP-lowering benefit in angle closure

August 6, 2019
No additional benefit in IOP-lowering effect was seen when goniosynechialysis was added to phacoemulsification in patients with primary angle closure…

19-gauge Ahmed micro stent cutter developed

July 26, 2019
MicroSurgical Technology and Ike Ahmed, MD, have developed the MST 19-gauge Ahmed micro stent cutter, according to a press release. The device allows…

PolyActiva completes enrollment in glaucoma implant trial

July 23, 2019
Patient enrollment in a phase 1 clinical trial of PolyActiva’s biodegradable, slow-release ocular implant for the treatment of glaucoma has…

Bimatoprost Sustained-Release application acceptance tops weekly news highlights

July 21, 2019
Here are some of the past week’s top stories:

In the Journals

Higher cholesterol levels associated with greater risk for primary open-angle glaucoma

July 18, 2019
Patients with higher levels of cholesterol are more at risk for primary open-angle glaucoma, while those who take statins to control cholesterol…

Nicox completes enrollment in NCX 470 trial

July 18, 2019
Enrollment is complete in a phase 2 clinical trial of NCX 470, Nicox’s second-generation nitric oxide-donating bimatoprost analog, for the…

FDA accepts application for Bimatoprost Sustained-Release

July 17, 2019
The FDA has accepted a new drug application for Bimatoprost Sustained-Release to reduce IOP in primary open-angle glaucoma or ocular hypertension…

iSTAR's MINIject shows positive 18-month results

July 12, 2019
iSTAR Medical’s MINIject device showed positive results in a first-in-human trial, with a mean pressure reduction of 15 mm Hg at 18 months…

New ocular health supplement targets glaucoma

July 10, 2019
Guardion Health Sciences Inc. announced the launch of GlaucoCetin, a propriety formula shown in a clinical trial to reverse mitochondrial dysfunction…

Netarsudil trial completes enrollment in Japan

July 10, 2019
Aerie Pharmaceuticals has completed enrollment in a phase 2 clinical trial of netarsudil ophthalmic solution in Japan, according to a press release…

Meeting NewsVideo

VIDEO: US launch of Rocklatan and other updates from Aerie

July 9, 2019
NEWPORT BEACH, Calif. — At OCTANe’s Ophthalmology Technology Summit, Tom Mitro, president and chief operating officer of Aerie…